Condition
Obese Subjects
Total Trials
5
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed4
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07461870Not ApplicableActive Not RecruitingPrimary
The Mediterranean Diet Based on Local Foods for Obese Patients
NCT07044167Not ApplicableCompleted
Innovative Functional Product for Overweight and Obesity
NCT06587932Not ApplicableCompletedPrimary
Brain Gym Exercises on Risk of Fall, Balance and Quality of Life in Obese Subjects
NCT06621186CompletedPrimary
Construction of an in Vitro Intestinal Microbial Ecological Simulation System for Obese People
NCT05815680Phase 1Completed
A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
Showing all 5 trials